Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who ...

A collaborative effort has shed valuable light on how monoamine neurotransmitters such as serotonin, dopamine, and now histamine help regulate brain physiology and behavior through chemical bonding of ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...